JAVELIN Bladder 100 Archives - Medical Conferences

First-line avelumab shows clinical activity in advanced urothelial carcinoma

Presented By

Dr Roberto Iacovelli, Catholic University of Rome, Italy

Trial

Phase 2, ARIES

Conference

ASCO GU 2022

Type

Peer-reviewed article

8 April 2022 11:17

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:41

Expert

Prof. Thomas Powles, Barts Cancer Institute, UK

Trial

Phase 3, JAVELIN Bladder 100

Conference

ASCO 2020

17 September 2020 14:30